Cornell University
Ithaca, New York, United States
Purpose
to develop a universal influenza vaccine using fragments of conserved viral proteins from multiple strains guided by immunogenicity screens using a large panel of human antibodies, to elicit more effective, and durable immune protection
Division
Global Health
Date
August 2019
Region Served
GLOBAL
Committed amount
$875,000
Grant topic
Pneumonia & Pandemic Preparedness
Duration (months)
46
Grantee location
Ithaca, New York, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.